Eversyn GmbH

A spin-off of the Max Planck Institute Magdeburg, eversyn pioneers cell-free biosynthesis, advancing beyond precision fermentation by designing multi-enzyme pathways for efficient production of activated sugars. This patented technology underpins commercially feasible production of high-value glycans, notably complex human milk oligosaccharides and tailored therapeutic protein glycosylation.